Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

Chateau Thomas; Bonovas Stefanos; Le Berre Catherine; Mathieu Nicolas; Danese Silvio; Peyrin-Biroulet Laurent

首页> 外文期刊>Journal of Crohn’s & colitis >Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

【24h】

Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

机译：Vedolizumab治疗炎症性肠病的外肠表现：系统评价

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background and Aims: We aimed to summarize existing data on the effectiveness of vedolizumab in extra-intestinal manifestations [EIMs] in inflammatory bowel disease [IBD].

机译：背景和目的：我们旨在总结韦多利单抗在炎症性肠病[IBD]肠外表现[EIMs]中的有效性的现有数据。

著录项

来源
《Journal of Crohn’s & colitis》 |2019年第12期|共9页
作者
Chateau Thomas; Bonovas Stefanos; Le Berre Catherine; Mathieu Nicolas; Danese Silvio; Peyrin-Biroulet Laurent;
展开▼
作者单位

Univ Grenoble Alpes Univ Hosp Grenoble Dept Hepatogastroenterol Grenoble France;

Humanitas Univ Dept Biomed Sci Milan Italy;

Nantes Univ Hosp Inst Malad Appareil Digestif Nantes France;

Univ Grenoble Alpes Univ Hosp Grenoble Dept Hepatogastroenterol Grenoble France;

Humanitas Univ Dept Biomed Sci Milan Italy;

Univ Lorraine Univ Hosp Nancy Dept Hepatogastroenterol Vandoeuvre Les Nancy France;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类杆菌传染病;
关键词
Anti-integrin therapy; extra-intestinal manifestations; inflammatory bowel disease;

机译：抗整联素治疗;超肠表现;炎症性肠病;

相似文献

外文文献
中文文献
专利

1. Prevalence and characteristics of ophthalmological extra-intestinal manifestations in Chinese patients with inflammatory bowel disease [J] . Ying-Chao Li1, Wei-Zhi Li1, Chang-Rui Wu2, 国际眼科杂志：英文版 . 2016,第010期
2. Association between inflammatory bowel diseases and Parkinson's disease: systematic review and meta-analysis [J] . Yu Zhu, Min Yuan, Yue Liu, 中国神经再生研究（英文版） . 2022,第002期
3. Vedolizumab in Inflammatory Bowel Disease: A Retrospective Review of Clinical Efficacy, Extra-intestinal Manifestations and Adverse Reactions [J] . Patel Ravi J., Grimes Ian The American Journal of Gastroenterology . 2016,第Suppla1期

机译：维多珠单抗在炎症性肠病中的临床疗效，肠外表现和不良反应的回顾性审查。
4. Real World Treatment Persistence With Vedolizumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis [J] . Demuth Dirk, Patel Haridarshan, Adsul Shashi The American Journal of Gastroenterology . 2018,第Suppla2期

机译：现实世界治疗持久性与炎症性肠病患者中的Vedolizumab：系统审查和荟萃分析
5. Systematic Review and Meta-Analysis: Preoperative Vedolizumab Treatment and Postoperative Complications in Patients with Inflammatory Bowel Disease [J] . Law Cindy C. Y., Narula Alisha, Lightner Amy L., Journal of Crohn’s & colitis . 2018,第5期

机译：系统评价和荟萃分析：术前Vedolizumab治疗和炎症性肠病患者的术后并发症
6. A Review of the Epidemiology of Inflammatory Bowel Disease with a Focus on Diet, Infections and Antibiotic Exposure [C] . James D. Lewis Nestlé Nutrition Workshop . 2014

机译：焦点对饮食，感染和抗生素暴露的炎症性肠病流行病学述评
7. Treatment of Iron Deficiency in Pediatric Patients with Inflammatory Bowel Disease [D] . ?Spaan, Jonathan 2020

机译：炎症性肠病患者缺铁缺乏的治疗方法
8. Crohn’s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab [O] . Aasem Abu Shtaya, Shai Cohen, Yana Kogan, 2021

机译：克罗恩病与vedolizumab治疗下的非典型肠道表现
9. Editorial: vedolizumab as a treatment and cause of extra-intestinal manifestations of inflammatory bowel disease [O] . M. L. Barclay, L. K. Stamp 2018

机译：编辑：Vedolizumab作为炎症性肠病患者肠外表现的治疗和原因
10. Treatment of Inflammatory Bowel Disease through Induction of Indoleamine 2.3-Dioxygenase. [R] . Gurtner, G., Gurtner, N., Stenson, W. F. 2004

机译：通过诱导吲哚胺2.3-双加氧酶治疗炎症性肠病。

Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

摘要

著录项

相似文献

相关主题

期刊订阅